Thursday, November 20, 2008 - 4:54AM EST

Review Articles

21. Management of the behavioral aspects of Parkinson's disease.

Author
Borek LL; Chou KL; Friedman JH;
Institution
Neurohealth Alzheimer's Disease and Movement Disorders Center, and Department of Geriatric Psychiatry, Butler Hospital, Warren Alpert Medical School of Brown University, RI, USA. leolisa@yahoo.com
Journal
Expert Rev Neurother. 2007 Jun;7(6):711-25.
Abstract URL
Click here to view abstract

22. Intervening in the neuropsychiatric features of Parkinson's disease.

Author
Weintraub D; Stern MB;
Institution
University of Pennsylvania School of Medicine, Department of Psychiatry, 3535 Market Sreet, Room 3003, Philadelphia, PA 19104, USA. weintrau@mail.med.upenn.edu
Journal
Expert Rev Neurother. 2007 Jun;7(6):699-710.
Abstract URL
Click here to view abstract

23. Stem cell therapy for Parkinson's disease.

Author
Takahashi J;
Institution
Kyoto University, Department of Biological Repair, Institute for Frontier Medical Sciences, Sakyo-ku, Kyoto 606-8507, Japan. jbtaka@frontier.kyoto-u.ac.jp
Journal
Expert Rev Neurother. 2007 Jun;7(6):667-75.
Abstract URL
Click here to view abstract

24. Frontiers in the surgical treatment of Parkinson's disease.

Author
Remple MS; Sarpong Y; Neimat JS;
Institution
Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Journal
Expert Rev Neurother. 2008 Jun;8(6):897-906.
Abstract URL
Click here to view abstract

25. Deep brain stimulation for Parkinson's disease.

Author
Limousin P; Martinez-Torres I;
Institution
Unit of Functional Neurosurgery, Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, University College London, London, England, United Kingdom. p.limousin@ion.ac.uk
Journal
Neurotherapeutics. 2008 Apr;5(2):309-19.
Abstract URL
Click here to view abstract

26. Treatment of Parkinson's disease with trophic factors.

Author
Peterson AL; Nutt JG;
Institution
Parkinsons Disease Research, Educational and Clinical Center, Portland Veteran's Administration Medical Center, Portland, Oregon 97239, USA.
Journal
Neurotherapeutics. 2008 Apr;5(2):270-80.
Abstract URL
Click here to view abstract

27. Spheramine for treatment of Parkinson's disease.

Author
Stover NP; Watts RL;
Institution
Department of Neurology, The University of Alabama at Birmingham, Birmingham, Alabama 35294, USA. npstover@uab.edu
Journal
Neurotherapeutics. 2008 Apr;5(2):252-9.
Abstract URL
Click here to view abstract

28. Protection against Parkinson's disease progression: clinical experience.

Author
LeWitt PA; Taylor DC;
Institution
Department of Neurology, Henry Ford Hospital, Detroit, Michigan, USA. palewitt@ameritech.net
Journal
Neurotherapeutics. 2008 Apr;5(2):210-25.
Abstract URL
Click here to view abstract

29. Current status of symptomatic medical therapy in Parkinson's disease.

Author
Factor SA;
Institution
Department of Neurology, Emory University School of Medicine, 1841 Clifton Road NE, Atlanta, Georgia 30329, USA. sfactor@emory.edu
Journal
Neurotherapeutics. 2008 Apr;5(2):164-80.
Abstract URL
Click here to view abstract

30. Depressive symptoms in Parkinson's disease.

Author
Lemke MR;
Institution
Department of Psychiatry, University of Kiel, Kiel, Germany. m.lemke@alsterdorf.de
Journal
Eur J Neurol. 2008 Apr;15 Suppl 1:21-5.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4 5 6 7 8 9 10